Two Sigma Advisers’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $1.62M | Sell |
|
|||||
|
2025
Q3 | $2.24M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $975K | Sell |
|
|||||
|
2023
Q4 | $937K | Buy |
|
|||||
|
2023
Q3 | $453K | Sell |
|
|||||
|
2023
Q2 | $452K | Buy |
|
|||||
|
2023
Q1 | $203K | Sell |
|
|||||
|
2022
Q4 | $270K | Sell |
|
|||||
|
2022
Q3 | $601K | Sell |
|
|||||
|
2022
Q2 | $1.58M | Sell |
|
|||||
|
2022
Q1 | $2.4M | Sell |
|
|||||
|
2021
Q4 | $4M | Buy |
|
|||||
|
2021
Q3 | $1.25M | Sell |
|
|||||
|
2021
Q2 | $1.67M | Sell |
|
|||||
|
2021
Q1 | $2M | Sell |
|
|||||
|
2020
Q4 | $1.66M | Buy |
|
|||||
|
2020
Q3 | $1.57M | Buy |
|
|||||
|
2020
Q2 | $1.33M | Buy |
|